GYN&CO
ActiveSummary
GYN&CO has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €150,040 and a net result of -€32,391. Equity is growing by ~10.2% per year across the filed fiscal years. Its solvency ranks better than 26% of 643 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability22▼-7
Solvency48▼-5
Growth52=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7,000 at 30 days acceptable
Liquidity short (current ratio 0.74 against 1.16 in 2024; short-term debt: 63.7% and cash: 17.8% of total assets), and 76.8% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
23.2%
Return on assets
-5%
Age of the figures
18 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
19202122232425
2019 to 2025 · latest year -€32,391
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 29-10-2025, 2 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
2 d early
2024
3 d early
2023
25 d early
2022
31 d early
2021
3 d early
2020
8 d early
2019
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 10 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 28 October (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
31-03-2026 close30-09-2026 today31-10-2026 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€32,391▼ 492%
2024 · -€5,474
Working capital
-€107,715
2024 · €56,426
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€143,419▼ 13.6%€184,047▲ 28.3%€62,926▼ 65.8%€111,023▲ 76.4%€87,917▼ 20.8%
Net result€35,396within the sector's middle half▼ 40.6%€72,214within the sector's middle half▲ 104%-€38,837below the sector's middle half-€5,474below the sector's middle half▲ 85.9%-€32,391below the sector's middle half▼ 492%
Equity€154,528within the sector's middle half▲ 29.7%€226,742within the sector's middle half▲ 46.7%€187,905within the sector's middle half▼ 17.1%€182,431within the sector's middle half▼ 2.9%€150,040within the sector's middle half▼ 17.8%
Total assets€496,257within the sector's middle half▲ 15.6%€533,073within the sector's middle half▲ 7.4%€542,110within the sector's middle half▲ 1.7%€658,989within the sector's middle half▲ 21.6%€645,934within the sector's middle half▼ 2.0%
Debt€341,729▲ 10.2%€306,331▼ 10.4%€354,205▲ 15.6%€476,558▲ 34.5%€495,894▲ 4.1%
Working capital€135,399within the sector's middle half▲ 42.8%€201,986within the sector's middle half▲ 49.2%€157,406within the sector's middle half▼ 22.1%€56,426within the sector's middle half▼ 64.2%-€107,715below the sector's middle half
Solvency31.1%within the sector's middle half▲ 3.4pp42.5%within the sector's middle half▲ 11.4pp34.7%within the sector's middle half▼ 7.9pp27.7%within the sector's middle half▼ 7.0pp23.2%within the sector's middle half▼ 4.5pp
Current ratio2.06within the sector's middle half▼ 0.532.55within the sector's middle half▲ 0.501.81within the sector's middle half▼ 0.741.16within the sector's middle half▼ 0.650.74below the sector's middle half▼ 0.42
Return on assets (ROA)7.1%within the sector's middle half▼ 6.7pp13.5%within the sector's middle half▲ 6.4pp-7.2%below the sector's middle half▼ 20.7pp-0.8%below the sector's middle half▲ 6.3pp-5.0%below the sector's middle half▼ 4.2pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 21% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €645,934
Fixed assets
€341,907 ▲ 37.5%
Current assets
€304,026 ▼ 25.9%
Equity and liabilities €645,934
Equity
€150,040 ▼ 17.8%
Debt
€495,894 ▲ 4.1%
Debt's share of the balance-sheet total rises from 72.3% to 76.8%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€139,867▼
2024 · €151,918
Cash flow
€19,559▼
2024 · €35,421
Debt to equity
3.31▲
2024 · 2.61
ROE
-21.6%▼
2024 · -3.0%
Interest coverage
1.15▼
2024 · 1.31
Debt ≤ 1 year
€411,741▲
2024 · €353,934
Debt > 1 year
€84,153▼
2024 · €122,623
Income taxes
-€241▼
2024 · €1,155
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 748 companies that looked in July 2024 the way this one looks now, 1.3% went bankrupt within 24 months and 97% are still going.
- Small
- 5 to 10 years old
- solvency 10 to 30%
- a small loss
1.3%
went bankrupt
1.9%
stopped otherwise
97%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 748 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €42,098 | €35,142 | €37,678 | €40,895 | €51,950 | ▲ 27.0% |
| Other operating charges640/8 | - | €704 | €645 | €3,750 | €514 | ▼ 86.3% |
| Gross operating margin9900 | €185,918 | €219,892 | €101,248 | €155,668 | €140,381 | ▼ 9.8% |
| Operating profit (loss)9901 | €143,419 | €184,047 | €62,926 | €111,023 | €87,917 | ▼ 20.8% |
| Financial income75/76B | - | - | - | €393 | €813 | ▲ 107% |
| Recurring financial income75 | - | - | - | €393 | €813 | ▲ 107% |
| Financial charges65/66B | - | €83,915 | €101,473 | €115,735 | €121,361 | ▲ 4.9% |
| Recurring financial charges65 | €99,493 | €83,915 | €101,473 | €115,735 | €121,361 | ▲ 4.9% |
| Profit (loss) for the period before taxes9903 | €43,925 | €100,132 | -€38,547 | -€4,319 | -€32,632 | ▼ 656% |
| Income taxes67/77 | €8,529 | €27,918 | €290 | €1,155 | -€241 | ▼ 121% |
| Profit (loss) for the period9904 | €35,396 | €72,214 | -€38,837 | -€5,474 | -€32,391 | ▼ 492% |
| Profit (loss) for the period to be appropriated9905 | €35,396 | €72,214 | -€38,837 | -€5,474 | -€32,391 | ▼ 492% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €496,257 | €533,073 | €542,110 | €658,989 | €645,934 | ▼ 2.0% |
| Fixed assets21/28 | €232,558 | €200,843 | €191,056 | €248,629 | €341,907 | ▲ 37.5% |
| Intangible fixed assets21 | €164,726 | €139,726 | €114,726 | €89,726 | €64,726 | ▼ 27.9% |
| Tangible fixed assets22/27 | €67,832 | €61,117 | €76,330 | €158,903 | €277,181 | ▲ 74.4% |
| Land and buildings22 | - | €60,466 | €55,086 | €140,840 | €269,731 | ▲ 91.5% |
| Furniture and vehicles24 | - | €651 | €21,243 | €18,063 | €7,451 | ▼ 58.8% |
| Current assets29/58 | €263,699 | €332,230 | €351,054 | €410,361 | €304,026 | ▼ 25.9% |
| Amounts receivable within one year40/41 | €1,105 | €126,882 | €157,395 | €153,715 | €187,982 | ▲ 22.3% |
| Trade receivables40 | - | €126,882 | €127,562 | €134,715 | €186,273 | ▲ 38.3% |
| Other amounts receivable41 | - | - | €29,833 | €19,000 | €1,709 | ▼ 91.0% |
| Cash at bank and in hand54/58 | €171,968 | €203,150 | €192,457 | €255,575 | €114,675 | ▼ 55.1% |
| Deferred charges and accrued income490/1 | - | €2,198 | €1,203 | €1,070 | €1,370 | ▲ 28.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €496,257 | €533,073 | €542,110 | €658,989 | €645,934 | ▼ 2.0% |
| Equity10/15 | €154,528 | €226,742 | €187,905 | €182,431 | €150,040 | ▼ 17.8% |
| Contributions10/11 | - | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €1,860 | €74,074 | €74,074 | €74,074 | €74,074 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | - | - |
| Distributable reserves133 | - | €72,214 | €72,214 | €72,214 | €74,074 | ▲ 2.6% |
| Profit (loss) carried forward14 | €140,268 | €140,268 | €101,431 | €95,958 | €63,566 | ▼ 33.8% |
| Amounts payable17/49 | €341,729 | €306,331 | €354,205 | €476,558 | €495,894 | ▲ 4.1% |
| Amounts payable after more than one year17 | €213,429 | €176,086 | €160,556 | €122,623 | €84,153 | ▼ 31.4% |
| Financial debts170/4 | - | €176,086 | €160,556 | €122,623 | €84,153 | ▼ 31.4% |
| Amounts payable within one year42/48 | €128,300 | €130,245 | €193,648 | €353,934 | €411,741 | ▲ 16.3% |
| Current portion of amounts payable after more than one year42 | - | €37,342 | €39,860 | €37,933 | €38,471 | ▲ 1.4% |
| Trade debts44 | €6,586 | €1,170 | €62 | €14,573 | €5,220 | ▼ 64.2% |
| Suppliers440/4 | - | €1,170 | €62 | €14,573 | €5,220 | ▼ 64.2% |
| Taxes, remuneration and social security45 | - | €19,231 | €1,354 | €2,304 | €3,408 | ▲ 47.9% |
| Taxes450/3 | - | €19,231 | €1,354 | €2,304 | €3,408 | ▲ 47.9% |
| Other amounts payable47/48 | - | €72,501 | €152,372 | €299,124 | €364,642 | ▲ 21.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €35,396 | €72,214 | -€38,837 | -€5,474 | -€32,391 | ▼ 492% |
| + Depreciation and write-downs630 | €42,098 | €35,142 | €37,678 | €40,895 | €51,950 | ▲ 27.0% |
| Operating cash flow (approximation) | €77,494 | €107,356 | -€1,159 | €35,421 | €19,559 | ▼ 44.8% |
| Investment in fixed assets (approximation) | - | -€3,427 | -€27,890 | -€98,468 | -€145,229 | ▼ 47.5% |
| Change in cash | - | €31,182 | -€10,693 | €63,118 | -€140,901 | ▼ 323% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
29-10
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2024
28-10
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2023
06-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
31-03
Financial
Weakest financial yearnet -€38,837
Net result drops to -€38,837, the lowest in the series; recovery starts the following year.
2022
30-09
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
31-03
Financial
Highest result since 2019net €72,214 ▲104%
Operating result €184,047, net result €72,214, both a record.
31-03
Financial
Equity above €200,000Eq €226,742 ▲46.7%
4 profitable years in a row build equity to €226,742.
2021
28-10
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
31-03
Financial
Equity above €150,000Eq €154,528 ▲29.7%
3 profitable years in a row build equity to €154,528.
2020
23-10
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
31-03
Financial
Equity above €100,000Eq €119,132 ▲99.9%
2 profitable years in a row build equity to €119,132.
2019
31-10
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Watermaal-Bosvoorde · 1 establishment unit since 2017
Ground area
906 m²
Building footprint
123 m²
Volume, LiDAR
1,264 m³
Parcel 21652E0291/00S002, Brussels · tallest building 14.1 m, ±4 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Delleurlaan 20, 1170 Watermaal-Bosvoorde
since 20172.270.427.728
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21652E0291/00S002 | Brussels | 905 m² | 1 · 123 m² | 14.1 m · 4 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
254900TTEI58XASB1N93
Similar companies · same sector, comparable size
OCULUX
BE 0803.897.002
Bree · Eq €150,000
DR. VAN LYSEBETH S-A PSYCHIATER
BE 0645.920.624
Kortrijk · Eq €149,942
DOCTEUR CAMILLE KOPETTI
BE 0784.931.720
Liège · Eq €150,142
DEJONGE NATHALIE
BE 0836.182.659
Namur · Eq €149,786
CSDL DERMATOLOGY
BE 0809.050.373
Ukkel · Eq €150,426
Of 16,627 companies in sector 86220 we hold annual accounts for 7,988. 6,753 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded02-11-2017
Fiscal year end31-03
Activities, NACEBEL 2025
86220Specialist medical practice
70200Business and other management consultancy
82990Other business support services
Contact
E-mail
laurencedellevigne@gmail.com
E-invoicing
Reachable via Peppol
Peppol ID
0208:0683924927
Also
9925:BE0683924927
Registered
26-05-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.